Famos en es it fr

Famos Brand names, Famos Analogs

Famos Brand Names Mixture

  • No information avaliable

Famos Chemical_Formula


Famos RX_link


Famos fda sheet

Famos FDA

Famos msds (material safety sheet)

Famos MSDS

Famos Synthesis Reference

H. Yasufumi et al.; U.S. Pat. 4,283,408 (1981)

Famos Molecular Weight

337.449 g/mol

Famos Melting Point

163-164 oC

Famos H2O Solubility

1.1 mg/mL

Famos State


Famos LogP


Famos Dosage Forms

Oral tablets; Rapid disintergrating tablets; Suspension; Injectable solution

Famos Indication

For the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD).

Famos Pharmacology

Famotidine, a competitive histamine H2-receptor antagonist, is used to treat gastrointestinal disorders such as gastric or duodenal ulcer, gastroesophageal reflux disease, and pathological hypersecretory conditions. Famotidine inhibits many of the isoenzymes of the hepatic CYP450 enzyme system. Other actions of Famotidine include an increase in gastric bacterial flora such as nitrate-reducing organisms.

Famos Absorption

The bioavailability of oral doses is 40-45%.

Famos side effects and Toxicity

Intravenous, mouse: LD50 = 244.4mg/kg; Oral, mouse: LD50 = 4686 mg/kg. Symptoms of overdose include emesis, restlessness, pallor of mucous membranes or redness of mouth and ears, hypotension, tachycardia and collapse.

Famos Patient Information

Famotidine is used to treat stomach and duodenal (upper small intestine) ulcers;
hypersecretory (increased acid secretion) conditions; heartburn and gastroesophageal
reflux disease (stomach contents bubbling into the esophagus causing pain). Notify your
physician if you are pregnant or nursing. Famotidine may be taken with or without food.
Shake the oral suspension vigorously for 5-10 seconds before taking. Unused oral
suspension should be discarded after 30 days. Notify your physician if you develop black,
tarry stools or coffee-ground vomit.

Famos Organisms Affected

Humans and other mammals